CXApp Financials
This page shows CXApp (CXAI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External financing is carrying operations as cash burn outruns revenue scale despite a high gross margin model.
The current ratio improved to 2.2x in FY2025, but that stronger liquidity was supplied by$16.6M of financing inflow rather than internally generated cash. With free cash flow still at-$10.4M , the business became more liquid and more financing-dependent at the same time, which is easy to miss if you look only at the year-end cash balance.
Gross margin rose to
Cash burn and accounting loss were fairly aligned in FY2025, with operating cash flow at
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of CXApp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
CXApp has an operating margin of -383.5%, meaning the company retains $-384 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -192.4% the prior year.
CXApp carries a low D/E ratio of 1.32, meaning only $1.32 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 75/100, indicating a strong balance sheet with room for future borrowing.
CXApp's current ratio of 2.23 indicates adequate short-term liquidity, earning a score of 41/100. The company can meet its near-term obligations, though with limited headroom.
While CXApp generated -$10.4M in operating cash flow, capex of $23K consumed most of it, leaving -$10.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
CXApp passes 2 of 9 financial strength tests. No profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
CXApp earns $-8788.5 in operating income for every $1 of interest expense (-$17.6M vs $2K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
CXApp generated $4.6M in revenue in fiscal year 2025. This represents a decrease of 35.8% from the prior year.
CXApp's EBITDA was -$17.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 28.3% from the prior year.
Cash & Balance Sheet
CXApp generated -$10.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 41.5% from the prior year.
CXApp held $11.1M in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
CXApp's gross margin was 87.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 5.4 percentage points from the prior year.
CXApp's operating margin was -383.5% in fiscal year 2025, reflecting core business profitability. This is down 191.1 percentage points from the prior year.
Capital Allocation
CXApp invested $6.6M in research and development in fiscal year 2025. This represents an increase of 4.0% from the prior year.
CXApp invested $23K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 23.3% from the prior year.
CXAI Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $950K-7.0% | $1.0M-8.3% | $1.1M-8.9% | $1.2M-0.1% | $1.2M-26.3% | $1.7M-12.4% | $1.9M+7.4% | $1.8M |
| Cost of Revenue | $160K+19.4% | $134K+8.9% | $123K-28.1% | $171K+14.0% | $150K-35.6% | $233K-37.4% | $372K+5.4% | $353K |
| Gross Profit | $790K-11.0% | $888K-10.4% | $991K-5.8% | $1.1M-2.0% | $1.1M-24.8% | $1.4M-6.4% | $1.5M+7.9% | $1.4M |
| R&D Expenses | $1.5M+0.7% | $1.5M+1.2% | $1.5M-32.7% | $2.2M+48.6% | $1.5M-1.5% | $1.5M-3.5% | $1.6M-10.3% | $1.7M |
| SG&A Expenses | $2.3M+17.6% | $2.0M-12.3% | $2.2M+32.7% | $1.7M-18.1% | $2.1M+38.3% | $1.5M-34.6% | $2.3M+28.8% | $1.8M |
| Operating Income | -$4.1M+30.1% | -$5.9M-54.1% | -$3.8M+7.0% | -$4.1M-9.8% | -$3.7M-32.8% | -$2.8M+23.5% | -$3.7M-1.0% | -$3.6M |
| Interest Expense | $17K | $0 | $0 | $0-100.0% | $2K-98.2% | $110K-65.3% | $317K-1.6% | $322K |
| Income Tax | $2K | N/A | N/A | $1K | N/A | -$122K+17.0% | -$147K+7.5% | -$159K |
| Net Income | -$4.0M+28.0% | -$5.6M-76.1% | -$3.2M-0.6% | -$3.1M-94.2% | -$1.6M+59.4% | -$4.0M+26.8% | -$5.4M-3.4% | -$5.3M |
| EPS (Diluted) | $-0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CXAI Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.0M+1.7% | $32.4M+13.6% | $28.5M-3.5% | $29.6M+1.1% | $29.3M-8.0% | $31.8M | N/A | N/A |
| Current Assets | $14.2M+10.6% | $12.8M+113.5% | $6.0M-3.7% | $6.2M+17.3% | $5.3M-24.9% | $7.1M | N/A | N/A |
| Cash & Equivalents | $12.3M+11.2% | $11.1M+118.2% | $5.1M+4.8% | $4.9M+24.7% | $3.9M-20.2% | $4.9M-4.0% | $5.1M-17.5% | $6.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $907K+15.0% | $789K+739.4% | $94K-88.5% | $818K+11.7% | $732K-56.6% | $1.7M | N/A | N/A |
| Goodwill | $6.6M0.0% | $6.6M-24.6% | $8.7M0.0% | $8.7M0.0% | $8.7M0.0% | $8.7M | N/A | N/A |
| Total Liabilities | $17.0M-7.6% | $18.4M+38.6% | $13.3M-12.8% | $15.3M+11.7% | $13.7M-15.8% | $16.2M | N/A | N/A |
| Current Liabilities | $6.2M+7.9% | $5.8M-14.3% | $6.7M-12.2% | $7.7M-18.0% | $9.3M-19.4% | $11.6M | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $15.9M+14.0% | $14.0M-8.2% | $15.2M+6.5% | $14.3M-8.3% | $15.6M0.0% | $15.6M+14.4% | $13.6M-16.2% | $16.3M |
| Retained Earnings | -$94.7M-4.4% | -$90.7M-6.5% | -$85.1M-3.9% | -$82.0M-4.0% | -$78.8M-2.1% | -$77.2M | N/A | N/A |
CXAI Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.2M+39.1% | -$3.6M-31.6% | -$2.8M+8.4% | -$3.0M-207.7% | -$979K+63.7% | -$2.7M-30.3% | -$2.1M-8.3% | -$1.9M |
| Capital Expenditures | $5K+150.0% | $2K-60.0% | $5K-54.5% | $11K+120.0% | $5K | $0-100.0% | $4K-50.0% | $8K |
| Free Cash Flow | -$2.2M+39.0% | -$3.6M-31.4% | -$2.8M+8.6% | -$3.0M-207.2% | -$984K+63.5% | -$2.7M-30.1% | -$2.1M-8.1% | -$1.9M |
| Investing Cash Flow | -$5K-150.0% | -$2K+60.0% | -$5K+54.5% | -$11K-120.0% | -$5K | $0+100.0% | -$4K+50.0% | -$8K |
| Financing Cash Flow | $3.5M-64.2% | $9.6M+221.6% | $3.0M | N/A | N/A | $2.5M+150.0% | $1.0M | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CXAI Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 83.2%-3.7pp | 86.9%-2.1pp | 89.0%+2.9pp | 86.0%-1.7pp | 87.8%+1.8pp | 86.0%+5.6pp | 80.4%+0.4pp | 80.0% |
| Operating Margin | -434.1%+142.8pp | -576.9%-233.5pp | -343.4%-7.2pp | -336.1%-30.2pp | -306.0%-136.2pp | -169.7%+24.5pp | -194.3%+12.4pp | -206.7% |
| Net Margin | -421.4%+122.8pp | -544.1%-260.7pp | -283.4%-26.7pp | -256.7%-124.6pp | -132.0%+107.5pp | -239.5%+47.0pp | -286.4%+11.2pp | -297.6% |
| Return on Equity | -25.1%+14.7pp | -39.8%-19.1pp | -20.7%+1.2pp | -21.9%-11.6pp | -10.4%+15.2pp | -25.5%+14.4pp | -39.9%-7.6pp | -32.3% |
| Return on Assets | -12.1%+5.0pp | -17.2%-6.1pp | -11.1%-0.4pp | -10.6%-5.1pp | -5.5%+7.0pp | -12.5% | N/A | N/A |
| Current Ratio | 2.29+0.1 | 2.23+1.3 | 0.89+0.1 | 0.82+0.2 | 0.57-0.0 | 0.61 | N/A | N/A |
| Debt-to-Equity | 1.07-0.3 | 1.32+0.4 | 0.87-0.2 | 1.07+0.2 | 0.88-0.2 | 1.04 | N/A | N/A |
| FCF Margin | -233.2%+122.3pp | -355.5%-107.4pp | -248.1%-0.9pp | -247.2%-166.8pp | -80.4%+81.9pp | -162.3%-53.0pp | -109.3%-0.7pp | -108.6% |
Similar Companies
Frequently Asked Questions
What is CXApp's annual revenue?
CXApp (CXAI) reported $4.6M in total revenue for fiscal year 2025. This represents a -35.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is CXApp's revenue growing?
CXApp (CXAI) revenue declined by 35.8% year-over-year, from $7.1M to $4.6M in fiscal year 2025.
What is CXApp's EBITDA?
CXApp (CXAI) had EBITDA of -$17.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is CXApp's gross margin?
CXApp (CXAI) had a gross margin of 87.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is CXApp's operating margin?
CXApp (CXAI) had an operating margin of -383.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is CXApp's free cash flow?
CXApp (CXAI) generated -$10.4M in free cash flow during fiscal year 2025. This represents a -41.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is CXApp's operating cash flow?
CXApp (CXAI) generated -$10.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are CXApp's total assets?
CXApp (CXAI) had $32.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are CXApp's capital expenditures?
CXApp (CXAI) invested $23K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does CXApp spend on research and development?
CXApp (CXAI) invested $6.6M in research and development during fiscal year 2025.
What is CXApp's current ratio?
CXApp (CXAI) had a current ratio of 2.23 as of fiscal year 2025, which is generally considered healthy.
What is CXApp's debt-to-equity ratio?
CXApp (CXAI) had a debt-to-equity ratio of 1.32 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is CXApp's cash runway?
Based on fiscal year 2025 data, CXApp (CXAI) had $11.1M in cash against an annual operating cash burn of $10.4M. This gives an estimated cash runway of approximately 13 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is CXApp's Piotroski F-Score?
CXApp (CXAI) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Can CXApp cover its interest payments?
CXApp (CXAI) has an interest coverage ratio of -8788.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is CXApp?
CXApp (CXAI) scores 19 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.